B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
Immune system detects foreign pathogens, distinguishes them from self-antigens and responds to defend human body. When this self-tolerance is disrupted, the overactive immune system attacks healthy tissues or organs and the autoimmune diseases develop. B cells and plasma cells contribute a lot to pa...
Main Authors: | Zheng Zhang, Qian Xu, Liang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1126421/full |
Similar Items
-
Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
by: Ke-Tao Jin, et al.
Published: (2021-02-01) -
Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01) -
B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential
by: Haodong Shang, et al.
Published: (2024-03-01) -
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01) -
Chimeric antigen receptor T cell therapies for multiple myeloma
by: Chao Wu, et al.
Published: (2019-11-01)